Skip to site menu Skip to page content

Daily Newsletter

Daily Newsletter

Barriers stopping US biotechs from running FIH trials on home soil

The survey data comes shortly after the US Government announced Operation Trialblazer to boost Phase I research in the US.

Abigail Beaney August 14 2026

GlobalData analysis shows that the US has lost its global market share of trials, with China seeing a significant uptick. Credit: Dark Artistic / Shutterstock.com

Unlock FREE Access to Premium Content

​Discover exclusive forecasts, analyst insights, and in-depth clinical trials industry analysis across drug development, clinical research, and trial innovation.

With a free Clinical Trials Arena profile, you can:

  • Access exclusive analyst commentary and expert insights
  • View premium forecasts and data-driven clinical trial intelligence
  • Stay up to date with clinical trial news, regulatory updates, and industry trends
  • Receive alerts when new premium content is published
Unlock free access
Already have an account? Login here

Powered by

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Browse reports

Newsletters by sectors

Pharmaceutical Technology open-new-tab

Medical Device Network open-new-tab

Hospital Management open-new-tab

View more newsletters

Sign up to the newsletter

 

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close